American Association for the Advancement of Science

AAAS R&D Funding Update December 8, 2003 (revised Jan. 23) -
FY 2004 Final Appropriations:

FY 2004 Federal R&D Climbs to Record High of $127 Billion;
Defense and Homeland Security Up, Other Programs Share in Modest Gains

(A Preview of Congressional Action on Research and Development in the FY 2004 Budget)

Go to:

-Highlights of Federal R&D in FY 2004

-R&D Appropriations for Key Agencies

-The FY 2004 R&D Budget in Historical Context

-Next Steps and Publication Information

-Table 1. Total R&D by Agency

-Table 2. Estimated Research by Agency

-Table 3. Major Functional Categories of R&D


PDF version of this document

Full Text of Congressional Action on R&D in the FY 2004 Budget

Complete set of 16 agency funding tables (17pp; PDF)

Detailed agency tables (PDF):

- Table. FY 2004 U.S. Department of Agriculture R&D

- Table.FY 2004 Department of Commerce R&D

- Table A. Department of Defense by Program

- Table B. Department of Defense by Agency

- Table C. Department of Defense S&T

- Table. Department of Energy R&D

- Table 1. FY 2004 National Institutes of Health R&D

- Table 2. FY 2004 Department of Health and Human Services R&D

- Table. Department of Homeland Security R&D

- Table. Department of the Interior R&D

- Table. Department of Transportation R&D

- Table. Environmental Protection Agency R&D

- Table. National Aeronautics and Space Administration R&D

- Table. National Science Foundation R&D

Detailed agency updates (including agency tables):

Department of Agriculture

Department of Commerce

Department of Defense

Department of Energy

Department of Homeland Security

Department of the Interior

Department of Transportation

Environmental Protection Agency

National Aeronautics and Space Administration

National Institutes of Health and HHS

National Science Foundation

Special Report on R&D Earmarks in the FY 2004 Budget

Supplemental Tables and Full-Color Charts (PDF):

Historical Table 1. Federal R&D by Agency, 1976-2004 (current dollars)

Historical Table 2. Federal R&D by Agency, 1976-2004 (CONSTANT FY 2003 dollars)

Chart. Trends in Federal R&D, FY 1976-2004

Chart. Selected Trends in Nondefense R&D, FY 1976-2004

Chart. Trends in Defense R&D, FY 1976-2004

Chart. Trends in Basic Research, FY 1976-2004

Chart. Trends in Federal R&D, FY 1990-2004 (DOD, NIH, NASA, NSF, DOE)

Chart. Trends in Federal R&D, FY 1990-2004 (USDA, DOC, DOI, DOT, EPA)

Chart. Trends in Nondefense R&D, Request vs. Actual, FY 1978-2004

Chart. Trends in Defense R&D, Request vs. Actual, FY 1978-2004

Chart. Trends in NSF R&D, Request vs. Actual, FY 1978-2004

Chart. Trends in National Institutes of Health R&D, Request vs. Actual, FY 1978-2004

This report is a summary of AAAS estimates and analyses of appropriations in the FY 2004 omnibus bill and final FY 2004 appropriations bills for federal R&D. This report is a preview of the forthcoming publication Congressional Action on Research and Development in the FY 2004 Budget (see the last page).

In late January, Congress finally approved a fiscal year (FY) 2004 omnibus appropriations bill that completes the FY 2004 federal budget process, and provides a record-setting $127 billion federal research and development (R&D) investment in FY 2004, a nearly $10 billion increase. But 93 percent of the increase goes to just three agencies: the Department of Defense (DOD), the Department of Homeland Security (DHS), and the National Institutes of Health (NIH). The other R&D funding agencies collectively see only modest increases in their R&D portfolios, with increases for some agencies offset by flat funding or cuts in others. President Bush is expected to sign the bill into law by the end of the month, just days before the FY 2005 budget process begins.

In late November, President Bush and the 108th Congress reached agreement on the final outline of FY 2004 appropriations. The FY 2004 omnibus appropriations bill (HR 2673) bundles together the 7 unfinished appropriations bills (to add to the 6 appropriations bills already signed into law). The House gave final approval on December 8, but procedural disputes in the Senate delayed final Senate approval  until January 22. The 1185-page omnibus bill throws together nearly $328 billion in federal discretionary spending for FY 2004 and is filled with budgetary maneuvers to fit under congressional budget targets, including a 0.59 percent across-the-board cut for all non-DOD appropriations, even for agencies whose budgets were signed into law in 2003. Although the President and Congress agreed to record increases for defense and international discretionary spending related to U.S. activities in Iraq and Afghanistan, they also agreed to restrain domestic spending. So even as the FY 2004 budget contains record-breaking investments in defense and homeland security R&D, there are only modest increases for nondefense R&D programs, with increases in some R&D funding agencies offset by flat funding or cuts in others.  

Every year, AAAS analyzes appropriations for R&D as signed into law and provides detailed estimates on the federal investment in R&D for the new fiscal year in the publication Congressional Action on Research and Development. The FY 2004 edition will be published online on January 27; because of the late completion of the FY 2004 budget, there will be no printed edition. The full text will be available on line on the AAAS R&D Web site (www.aaas.org/spp/rd). Detailed information on the largest R&D funding agencies, historical tables, and other supplemental materials are now available on the AAAS R&D Web site.

 Highlights of Federal R&D in FY 2004: DOD, DHS, and NIH Get the Largest Increases

 The just-approved omnibus bill provides funding for 8 of the 12 largest R&D funding agencies, but also affects the other four agencies whose budgets have already been signed into law. The omnibus bill contains across-the-board cuts for all agencies other than DOD, even for agencies such as the Department of Energy (DOE) with enacted FY 2004 budgets, and also adds extra funds for DOD, DOE, and other agencies covered by other appropriations bills. (All figures are adjusted to reflect an across-the-board cut of 0.59 percent for all agencies other than DOD, and additional across-the-board cuts for selected agencies. The figures are also adjusted for rescissions and supplementals in the omnibus bill and the FY 2004 war supplemental.)

 - The federal investment in research and development (R&D) hits a new record of $127.0 billion in FY 2004, a $9.5 billion or 8.1 percent increase over FY 2004 (see Table 1 and Figure 1). Congress provided $4.6 billion more than the Bush Administration request.

 
Figure 1.
(click on the image to view or download a full-page version of this chart)

- The Department of Defense (DOD), the Department of Homeland Security (DHS), and the National Institutes of Health (NIH) get 93 percent of the $9.5 billion increase, leaving all other R&D funding agencies collectively with only a modest increase in funding. 80 percent of the increase goes just to DOD’s R&D, which hits another all-time high of $66.3 billion, a boost of 13.0 percent or $7.6 billion. DOD weapons systems development accounts for nearly all of the increase (up $6.3 billion to $53.7 billion), but Congress also rewarded DOD’s “S&T” activities with a 12.0 percent increase to $12.6 billion. The new DHS sees its R&D portfolio surge by 56.0 percent or $375 million to $1.0 billion.

- After five years of annual 15 percent increases, NIH budget growth slows down considerably in FY 2004. Most NIH institutes receive increases of about 3 percent. After adjusting for an across-the-board cut, the NIH R&D portfolio increases by 3.2 percent, a modest increase in percentage terms (see Figure 2). The omnibus bill adds $847 million to NIH R&D for a total of $27.1 billion.

 

Figure 2. (click on the image to view or download a full-page version of this chart)

- NIH and homeland security R&D are the primary growth areas in nondefense R&D, leaving all other domestic R&D priorities with flat funding overall. Nondefense R&D increases $1.6 billion or 2.9 percent to $56.0 billion (see Figure 1), but taking out the NIH increase leaves a smaller $750 million or 2.7 percent increase to $28.9 billion (see Table 1). Nearly all of that increase goes to nondefense R&D in DHS, and even at NIH much of the increase goes to biodefense research related to homeland security.

- The National Science Foundation (NSF) enjoys a budget increase, but falls well short of a five-year doubling plan signed into law last December. Congress provided $4.1 billion for NSF’s R&D activities (excluding education, training, and overhead programs), an increase of 4.7 percent (see Table 1 and Figure 2). The NSF research directorates receive increases between 3 and 7 percent. The total NSF budget of $5.6 billion is $1 billion short of the $6.6 billion authorized for FY 2004 by an NSF authorization bill signed into law last December that would put the NSF budget on track to double between FY 2002 and FY 2007.

- The remaining agencies in the federal R&D portfolio receive some modest increases offset by cuts or flat funding in other areas (see Figure 2). The Department of Energy’s (DOE) Office of Science received a modest boost to $3.2 billion for its R&D programs, an increase of 3.8 percent. R&D in the U.S. Geological Survey (USGS) fails to keep pace with inflation with a 1.7 percent increase to $579 million, although Congress reversed the Administration’s proposed cuts. Congress rejected the Administration’s proposal to eliminate the Advanced Technology Program, but R&D in the National Institute of Standards and Technology (NIST) in Commerce still declines 3.9 percent. There are cuts in the R&D portfolios of other agencies: R&D in the U.S. Department of Agriculture (USDA, down 4.9 percent), the Department of Transportation (DOT, down 8.2 percent), and NASA (down 0.4 percent) all fall in the FY 2004 omnibus bill.

- The federal basic and applied research portfolio increases 5.7 percent in FY 2004. The federal research portfolio (basic and applied research, including defense research) totals $56.0 billion in FY 2004 (see Table 2). Many agencies’ research portfolios fare better than their overall R&D portfolios because R&D facilities funding falls sharply in agencies such as USDA, DOE, and NIH, allowing for larger increases in research. NIH’s research portfolio increases 7.0 percent or $1.7 billion to $26.9 billion, as one-time grants for biodefense research facilities construction in FY 2003 are replaced by biodefense research grants in FY 2004; similarly, DOE research funding jumps 8.7 percent to $5.6 billion as facilities construction costs for the Spallation Neutron Source and the National Ignition Facility fall in FY 2004, allowing for research increases. NIH supports 48 percent of all federal research in FY 2004, a ratio that has been steadily increasing for decades.

 - The current focus on defense and homeland security results in large increases for defense and general science R&D, and modest increases or cuts for most of the other national missions (see Table 3). Defense R&D (including DOD, the Department of Energy’s defense activities, and a large part of the DHS R&D portfolio) rises $7.9 billion or 12.5 percent to $70.9 billion for a record total driven by substantial boosts to defense-related development activities in DOD and DHS. After several years of near-parity between defense and nondefense R&D around the turn of the century, defense R&D pulls ahead to 55.9 percent of total federal R&D. Because of the tremendous growth in defense and health R&D over the past few years, R&D for all other national missions has steadily shrunk to less than a quarter of the federal R&D portfolio and totals just 21 percent in FY 2004.

- R&D earmarks total $1.9 billion in FY 2004, up sharply from last year, according to the AAAS analysis of congressionally designated, performer-specific R&D projects in the FY 2004 appropriations bills. Although these projects amount to only 1.5 percent of total R&D, they are concentrated in a few key agencies and programs. Four agencies (USDA, $220 million; NASA, $194 million; DOE, $284 million; and DOD, $825 million) receive 80 percent of the total R&D earmarks, while NIH and NSF remain earmark-free. FY 2004 earmarks are up 32 percent from the $1.4 billion in FY 2003. (For full details see the AAAS R&D Funding Update on R&D Earmarks in the FY 2004 Budget, available on the FY 2004 R&D page of the AAAS R&D web site).

R&D Appropriations for Key Agencies

 Full information on final FY 2004 funding levels and program details for individual agencies are now available in newly revised AAAS R&D Funding Updates on the AAAS R&D Web site. (The on-line version of this document features links to the updates; see also the agency chapters in Congressional Action on R&D in the FY 2004 Budget.)

 - After a completed five-year doubling campaign involving 15 percent increases for each of the past five years, growth in the National Institutes of Health (NIH) budget slows sharply in FY 2004, leaving nearly all the NIH institutes with increases of about 3 percent. Congress added to the Administration’s request slightly for a total NIH budget (including non-R&D items and after adjusting for an across-the-board cut) of $28.0 billion, just 3.2 percent above last year. Biodefense research continues to be a high priority in FY 2004. The FY 2004 omnibus bill provides $4.3 billion for the National Institute of Allergy and Infectious Diseases (NIAID), the lead NIH institute for biodefense research, a boost of 16.3 percent over FY 2003 after a 47 percent boost last year. NIH research (basic and applied) increases 7.0 percent to $26.9 billion, greater than the increases for the overall NIH budget because Congress went along with NIH’s plan to discontinue most of its FY 2003 facilities funding and shift the money to biodefense research in FY 2004 (see Table 2).

 - The Department of Defense (DOD) has already received a record-breaking $66.3 billion for its R&D programs in FY 2004, a jump of 13.0 percent or $7.6 billion over FY 2003 (see Table 1).  Funding for missile defense development jumps 19 percent to $8.2 billion in FY 2004, mostly in the Missile Defense Agency; funding for other big development projects also climbs, particularly a $4.3 billion appropriation for the Joint Strike Fighter (up 27 percent). DOD’s support of basic research declines in FY 2004, while applied research increases modestly. Basic research (“6.1”) declines $13 million (0.9 percent) to $1.4 billion, while applied research (“6.2”) increases 3.6 percent to $4.4 billion, in contrast to requested cuts of 8 percent and 14 percent, respectively. DOD “Science and Technology” (S&T) programs, which include research, medical research, and early technology development, receive a record $12.6 billion in FY 2004, an increase of 12.0 percent, primarily because of large increases for technology development (“6.3”) programs. Congress agreed to DOD’s proposal to reorganize its basic research portfolio in FY 2004 by transferring many basic research programs funded in the Office of the Secretary of Defense (OSD) to the three services.

 - The Department of Homeland Security (DHS) becomes one of the major funding sources of R&D in FY 2004. The DHS R&D portfolio totals $1.04 billion in FY 2004, up 56 percent from FY 2003 (after adjusting for an across-the-board cut; see Table 1). Congress decided to fund the non-R&D Project Bioshield to procure biodefense countermeasures, a program first proposed in the President’s 2003 State of the Union address. The final DHS budget contains $5.6 billion over 10 years for biodefense countermeasures, of which $890 million is available in FY 2004, and which should provide incentives for private-sector R&D investments. The new S&T Directorate in the DHS has $869 million for R&D activities, 67 percent more than the current funding level, including $70 million for university programs and $60 million for R&D on antimissile devices for commercial aircraft.

- Congress provides $5.6 billion for the budget of the National Science Foundation (NSF) in FY 2004, $268 million or 5.0 percent more than FY 2003. NSF’s R&D activities receive $4.1 billion, an increase of 4.7 percent. The research directorates receive increases between 3 and 7 percent. The final appropriation falls nearly $1 billion short of the authorized funding level contained in the NSF authorization bill signed into law last December, which envisions a possible doubling of the NSF budget between FY 2002 and FY 2007.

- The Department of Energy (DOE) already has an R&D budget of $8.7 billion in FY 2004, an increase of $506 million or 6.1 percent, although the omnibus bill applies across-the-board cuts to its already-enacted budget. DOE’s Office of Science receives $3.2 billion for R&D after the across-the-board cut, a boost of 3.8 percent or $116 million in contrast to a requested cut. Congress added funds for high-performance computing research, domestic fusion research, and for more than 90 congressionally designated projects. Congress trimmed slightly the request for DOE’s defense R&D activities, but still provided a $257 million or 6.7 percent increase for a total of $4.1 billion, including research funds for a new generation of ‘bunker buster’ nuclear weapons. On the energy side, the increases are larger for an energy R&D total of $1.4 billion, up 10.4 percent. The final DOE budget boosts funding for R&D on hydrogen, nuclear energy, and coal, but cuts spending on other renewable energy areas and on other fossil fuels. The additions and cuts mirror the priorities outlined in the stalled FY 2004 energy policy bill, which fell just short of final Senate approval in late November. (The AAAS analysis of the R&D implications of the energy policy bill is available on the AAAS R&D web site.)

 - NASA will be preoccupied in FY 2004 with getting the Space Shuttle and International Space Station programs back on track after the Columbia shuttle disaster. Congress provides $15.4 billion for the NASA budget in FY 2004, even with FY 2003. NASA’s R&D funding declines 0.4 percent to $11.0 billion, primarily because construction funding for the R&D laboratory known as the International Space Station falls 19 percent to $1.5 billion while the project awaits the return to flight of the Space Shuttle. There will be increased attention to future launch alternatives to the Space Shuttle such as the Orbital Space Plane. NASA’s non-human space flight R&D programs in Science, Aeronautics and Exploration (SAE) receive 5.9 percent more in FY 2004 for a total of $7.9 billion, including a 12 percent boost for Space Science programs to $4.0 billion and a 6 percent boost to Biological and Physical Research to $990 million.

 - The Department of Commerce avoided steep proposed cuts to its R&D programs. Although the Bush Administration and the House proposed to eliminate the Advanced Technology Program in the National Institute of Standards and Technology (NIST), the FY 2004 omnibus bill sides with the Senate in keeping the program alive at last year’s funding level. NIST’s intramural R&D programs, however, decline 5.7 percent to $291 million despite a requested increase. And Congress essentially agreed to the Administration’s proposal to phase out the federal role in the non-R&D Manufacturing Extension Partnership (MEP), slashing funding by 63 percent down to $39 million. Total NIST R&D falls 3.9 percent to $506 million. For the National Oceanic and Atmospheric Administration’s (NOAA) R&D programs in ocean research, fisheries research, atmospheric science, and climate change science, Senate proposals for increases prevailed against House and Administration proposals for steep cuts. Total NOAA R&D rises 5.8 percent to $724 million. NOAA’s core R&D programs in Oceanic and Atmospheric Research gain 6.1 percent for a total of $361million.

 - The U.S. Department of Agriculture’s (USDA) R&D falls 4.9 percent or $111 million in the FY 2004 omnibus bill to $2.2 billion in FY 2004, primarily because of steep cuts to research facilities funding. The FY 2003 USDA budget included one-time emergency funds for construction and security upgrades at USDA laboratory facilities related to biodefense concerns. Without the facilities funds, USDA R&D actually increases slightly by 1.8 percent. Although USDA requested $200 million for the National Research Initiative of competitively awarded extramural research grants, Congress provides only $164 million, $36 million less than the request and $2 million less than FY 2003. Congress instead provides $111 million for the congressionally earmarked Special Research Grants, as well as $131 million in other intramural and extramural earmarked research grants.

 - The Environmental Protection Agency (EPA) budget in FY 2004 rises slightly, as does its R&D funding. The total EPA budget is $8.4 billion in the omnibus bill, $287 million more (3.5 percent) than FY 2003. EPA’s R&D funding rises 1.6 percent to $634 million, primarily because one-time emergency funding for building decontamination research in FY 2003 is replaced by $56 million in earmarked R&D projects. Most of EPA’s core R&D programs receive increased funding compared to FY 2003.

 - In an already-enacted spending bill, the U.S. Geological Survey (USGS), Interior’s lead science agency, received $579 million for its R&D programs, $10 million or 1.7 percent above the FY 2003 funding level (after adjusting for an across-the-board cut in the omnibus bill). Congress reversed the Bush Administration’s proposed cuts to many of USGS’ earth science and water resources research programs.  Total Interior R&D climbs $49 million or 7.9 percent to $676 million because of a requested boost to the Bureau of Land Management’s R&D activities.

 - Congress slashes R&D in the Department of Transportation (DOT) by $58 million or 8.2 percent to $644 million in FY 2004. The cuts hit both of DOT’s major R&D agencies, the Federal Aviation Administration (FAA) and the Federal Highway Administration (FHWA), both of which are primarily funded through trust funds whose receipts from transportation taxes have recently declined.

- The Department of Veterans Affairs (VA) has an R&D portfolio of $820 million in FY 2004, an increase of 2.5 percent. VA’s research is performed inside its network of VA hospitals and clinics by VA personnel, and focuses on health issues with impacts on the nation’s veterans.

The FY 2004 R&D Budget in Historical Context

The FY 2004 budget process leaves key R&D programs with flat budgets for the better part of the past decade. As shown in Figure 3 and Figure 4 show, both the defense and nondefense R&D investments are at record highs in FY 2004, but these totals disguise flat or declining funding for many areas.

 For defense R&D, Figure 3 shows that nearly all of the increases in the past few years to defense R&D have been in weapons systems development, “6.4” or higher in the DOD classification system. DOD’s S&T investments (“6.1” through “6.3”), comprising basic and applied research and technology development, are still well below the funding levels of the late 1980s and have received relatively modest increases compared to weapons development. The S&T accounts fund all of DOD’s investments in research, including key federal contributions to the support of the physical sciences, engineering, and other research fields.


Figure 3.
(click on the image to view or download a full-page version of this chart)


Figure 4.
(click on the image to view or download a full-page version of this chart)

In nondefense R&D, record-setting funding levels are primarily a legacy of the recently completed campaign to double the NIH budget between 1998 and 2003, as shown in Figure 4. All the other nondefense R&D funding agencies collectively have seen their budgets remain flat for more than a decade, even as the U.S. economy, the federal budget, and the U.S. population have all boomed during that time. Recent increases in nondefense R&D have served only to recover the lost ground of the mid-1990s when discretionary spending declined in the push to balance the federal budget. These non-NIH agencies, combined with DOD’s research investments, fund nearly all of the federal investment in the non-biomedical sciences, including the physical sciences, non-medical life sciences, environmental sciences, engineering, mathematics, computer sciences, and social sciences. Because of stagnant funding for DOD research and non-NIH nondefense R&D, federal support for these disciplines has remained stagnant for more than a decade, and the FY 2004 budget does little to change the trend.

 Next Steps and Publication Information

 The House of Representatives gave final approval to the FY 2004 omnibus bill on December 8, thereby concluding its business for the year. The Senate left for the year the next day without voting on the omnibus, and finally approved the omnibus bill on January 22. President Bush is expected to sign the bill into law and thereby conclude the FY 2004 budget process by the end of January.

 The AAAS publication Congressional Action on Research and Development in the FY 2004 Budget will be available on January 27. The full report will be available online only and will not be available this year in a printed edition. The full report will offer 16 detailed funding tables, several charts, a chronology of the events in the FY 2004 budget process, an analysis of funding trends, and analyses of the impacts of the FY 2004 budget on each of the major R&D funding agencies. Individual agency analyses, historical tables, agency funding tables, and charts of recent funding trends are already available on the AAAS R&D Web site in the “FY 2004 R&D” section.

- December 8, 2003 (revised Jan. 23)

AAAS R&D Budget and Policy Program
American Association for the Advancement of Science
1200 New York Ave, NW
Washington, DC 20005
(202) 326-6607
science_policy@aaas.org
http://www.aaas.org/spp/rd

Go to Tables 1-3

.

 

American Association for the Advancement of Science